AR121912A1 - Compuestos terapéuticos - Google Patents

Compuestos terapéuticos

Info

Publication number
AR121912A1
AR121912A1 ARP210101080A ARP210101080A AR121912A1 AR 121912 A1 AR121912 A1 AR 121912A1 AR P210101080 A ARP210101080 A AR P210101080A AR P210101080 A ARP210101080 A AR P210101080A AR 121912 A1 AR121912 A1 AR 121912A1
Authority
AR
Argentina
Prior art keywords
methyl
tetrahydroisoquinoline
methylcyclohexane
fluoro
carbonyl
Prior art date
Application number
ARP210101080A
Other languages
English (en)
Spanish (es)
Inventor
Cathy Louise Lucas
Nicholas Charles Ray
Eileen Mary Seward
George Hynd
Original Assignee
C4X Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C4X Discovery Ltd filed Critical C4X Discovery Ltd
Publication of AR121912A1 publication Critical patent/AR121912A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP210101080A 2020-04-22 2021-04-22 Compuestos terapéuticos AR121912A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2005863.2A GB202005863D0 (en) 2020-04-22 2020-04-22 Therapeutic compounds

Publications (1)

Publication Number Publication Date
AR121912A1 true AR121912A1 (es) 2022-07-20

Family

ID=70860156

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101080A AR121912A1 (es) 2020-04-22 2021-04-22 Compuestos terapéuticos

Country Status (16)

Country Link
US (1) US20230167084A1 (cg-RX-API-DMAC7.html)
EP (1) EP4139294B1 (cg-RX-API-DMAC7.html)
JP (1) JP7679400B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230004720A (cg-RX-API-DMAC7.html)
CN (1) CN115667243B (cg-RX-API-DMAC7.html)
AR (1) AR121912A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021259366A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022021244A2 (cg-RX-API-DMAC7.html)
CA (1) CA3174361A1 (cg-RX-API-DMAC7.html)
ES (1) ES3032247T3 (cg-RX-API-DMAC7.html)
GB (1) GB202005863D0 (cg-RX-API-DMAC7.html)
IL (1) IL297434A (cg-RX-API-DMAC7.html)
MX (1) MX2022013398A (cg-RX-API-DMAC7.html)
PH (1) PH12022552775A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021214470A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202211465B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY207469A (en) * 2018-10-22 2025-02-27 C4X Discovery Ltd Therapeutic compounds
CR20240325A (es) * 2022-01-07 2024-11-22 Chugai Pharmaceutical Co Ltd Compuesto heterocíclico que contiene nitrógeno que tiene un efecto de activación del nrf2
WO2025237912A1 (en) 2024-05-13 2025-11-20 Astrazeneca Ab Keap1 inhibitors for use in the treatment of bronchiectasis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649606B1 (en) 2001-11-09 2003-11-18 Bristol-Myers Squibb Co. Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
US20140256767A1 (en) * 2011-10-31 2014-09-11 The Broad Institute, Inc. Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
KR20180017038A (ko) * 2015-06-15 2018-02-20 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Nrf2 조절제
JP2020097526A (ja) 2017-03-28 2020-06-25 武田薬品工業株式会社 複素環化合物
MY207469A (en) 2018-10-22 2025-02-27 C4X Discovery Ltd Therapeutic compounds

Also Published As

Publication number Publication date
JP2023524206A (ja) 2023-06-09
EP4139294B1 (en) 2025-04-09
EP4139294A1 (en) 2023-03-01
JP7679400B2 (ja) 2025-05-19
CN115667243A (zh) 2023-01-31
KR20230004720A (ko) 2023-01-06
CA3174361A1 (en) 2021-10-28
MX2022013398A (es) 2022-12-13
US20230167084A1 (en) 2023-06-01
ZA202211465B (en) 2025-06-25
AU2021259366A1 (en) 2022-11-10
GB202005863D0 (en) 2020-06-03
WO2021214470A1 (en) 2021-10-28
PH12022552775A1 (en) 2024-03-25
BR112022021244A2 (pt) 2022-12-06
CN115667243B (zh) 2025-01-07
IL297434A (en) 2022-12-01
ES3032247T3 (en) 2025-07-16

Similar Documents

Publication Publication Date Title
US11912703B2 (en) 6-azaindole compounds
KR102641030B1 (ko) Pd-l1 내재화 유도제로서의 테트라하이드로 이미다조[4,5-c]피리딘 유도체
JP7549627B2 (ja) Axlインヒビタおよび免疫チェックポイントモジュレータまたは腫瘍溶解性ウィルスによる併用療法
KR102755258B1 (ko) Tlr 억제제로서 유용한 아미드 치환된 인돌 화합물
AU2017307208B2 (en) Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors
JP7382938B2 (ja) ジアザインドール化合物
KR102714788B1 (ko) Tlr 억제제로서 유용한 아미노 인돌 화합물
KR102473482B1 (ko) [1,2,4]트리아졸로[1,5-a]피리디닐 치환된 인돌 화합물
JP7287964B2 (ja) 置換インドールエーテル化合物
CA2903394C (en) Arginine methyltransferase inhibitors and uses thereof
CA3155569A1 (en) Polyheterocyclic modulators of sting (stimulator of interferon genes)
JP2018538269A (ja) 免疫調節剤としての複素環化合物
KR20110137364A (ko) 축합 피롤로피리딘 유도체
JP2021506889A (ja) Tlr阻害剤として有効な置換されたインドール化合物
JP2014111641A (ja) Axlインヒビターとして有用なN3−ヘテロアリール置換トリアゾールおよびN5−ヘテロアリール置換トリアゾール
UA121658C2 (uk) Сполуки 5-хлордифторметоксифенілпіразолопіримідину як інгібітори янус-кінази
JP7597709B2 (ja) 置換インドールおよびインダゾール化合物
EP4225445A2 (en) Heterocyclic inhibitors of egfr and/or her2, for use in the treatment of cancer
KR102950614B1 (ko) 항암제로서의 시클릭 디뉴클레오티드
WO2021074279A1 (en) Spiro-fused tricyclic map4k1 inhibitors
KR20220079587A (ko) 치환된 카르바졸 화합물
JP6454346B2 (ja) 芳香族複素環式化合物及び医薬におけるその応用
KR20230052930A (ko) Tlr9의 억제제로서 유용한 치환된 헤테로아릴 화합물
AR117037A1 (es) Compuestos pirazol para el tratamiento de enfermedades autoinmunitarias
AR127450A1 (es) Moduladores del receptor ccr6